Find the products and resources you are looking for!
Miltenyi Biotec distribution:
As a global market leader with numerous subsidiaries and distributors, Miltenyi Biotec is committed to providing our customers around the world with the highest quality products. In addition to direct selling in more than 20 countries in North America, Europe and Asia/Pacific, Miltenyi Biotec also provides support for our customers through an extensive distributor network covering dozens of additional countries.
CARAT is a EU-funded project aiming to integrate innovative cell manufacturing technologies into a new, comprehensive platform that will facilitate the safe, automated, and cost-efficient manufacture of highly effective CAR T cells. Thus, CARAT is taking on the mission to deliver new methods to enable the wide use of novel personalized cancer treatment options based on highly innovative cell therapies. The project consortium comprises a multi-national team of leading experts from eight European partnering institutions.
In 2017 and 2018 two unique training events were performed by CARAT to transfer knowledge on GMP-compliant CAR T cell manufacturing to scientists in the field. Based on the high interest and the huge success of both training events, CARAT will offer a third training event in 2019 to reach an even higher number of scientists. The course is limited to a maximum of six attendees. It will take place at Miltenyi Biotec´s headquarter in Germany in December 2019 and focuses on practical, regulatory, and scientific issues. Applicants from EU Member States and Associated Countries are encouraged to participate.
Scientists with a profound background in cellular and gene therapy, who intend to initiate clinical applications in the near future.
The training event will take place on December 09-13, 2019 in Bergisch Gladbach, Germany.
MACS Academy at Miltenyi Biotec Headquarters
51429 Bergisch Gladbach
1. Submission deadline for applications: June 30, 2019. Applications should be sent electronically in a single pdf document to Janine Jost (firstname.lastname@example.org).
2. Applications must be written in English and should provide the following information:
All applications will be reviewed based on the following criteria:
Submitted applications will be peer-reviewed by the CARAT Steering Committee (composed of a principal investigator from each partner of CARAT), taking into account scientific aspects as well as gender equality and regional aspects.
The applicants will be informed about the outcome of the evaluation process 3 months after the application deadline at the latest.
CARAT reserves the right to adapt the timelines of the procedure in case of unexpected events.
Copyright © 2020 Miltenyi Biotec and/or its affiliates. All rights reserved.